RecruitingNCT06208397

MRE for Assessment of Histopathological Growth Patterns in Colorectal Liver Metastases

Noninvasive Evaluation in Diagnosis and Treatment of Histopathological Growth Patterns in Colorectal Liver Metastases Using MR Elastography-based Shear Strain Mapping


Sponsor

Shengjing Hospital

Enrollment

50 participants

Start Date

Dec 24, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this study is to investigate the value of MR elastography-based SII as a means of detecting HGP noninvasively in patients with pathology-proven CRLM. MRE will provide a direct measure of tumor-liver adhesion to investigate the relationship between imaging findings and pathophysiological changes in the Liver.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria3

  • Diagnosed CRLM
  • Pathologic results obtained in surgical patients
  • No contraindications for magnetic resonance imaging examination

Exclusion Criteria6

  • Image quality does not meet the measurement requirements.
  • the diameter of CRLM \<1cm
  • Combined with other important organ dysfunction
  • Combined with malignant tumor
  • Patients who do not sign an informed consent
  • Patients with metallic implants or foreign bodies in their bodies (pacemakers, artificial metallic heart valves, metal joints, metal implants, and those who cannot remove dentures, insulin pumps, or contraceptive rings)

Interventions

DIAGNOSTIC_TESTMagnetic Resonance Elastography and routine MRI

Assessed boundary conditions through MRE-base SII before surgery and recorded HGP of tumor after surgery.


Locations(1)

Shengjing Hospital of China Medical University

Shenyang, Liaoning, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06208397


Related Trials